Filter
3098
Filtered Results: 3098
Text search:
adverse
events
Featured
Recommendations
347
New Publications
760
Language
Document type
No document type
1618
Guidelines
531
Studies & Reports
508
Manuals
188
Strategic & Response Plan
99
Fact sheets
65
Training Material
44
Situation Updates
20
Infographics
10
Resource Platforms
5
Online Courses
4
Videos
3
Brochures
2
App
1
Countries / Regions
India
146
Global
121
Western and Central Europe
73
South Africa
73
Kenya
66
Ethiopia
59
Latin America and the Carribbean
46
Africa
45
Nigeria
43
Uganda
43
Nepal
39
Ghana
37
Tanzania
36
Bangladesh
35
Sierra Leone
33
Zambia
29
Myanmar / Burma
29
Philippines
28
Malawi
26
Liberia
26
Eastern Europe
25
Ukraine
23
South–East Asia Region
23
Rwanda
20
Cambodia
18
Syria
17
Zimbabwe
15
Namibia
15
Asia
13
Guinea
12
USA
12
Eastern Europe and Central Asia
12
East and Southern Africa
12
Brazil
12
South Sudan
12
Lesotho
11
Colombia
10
Botswana
10
Indonesia
10
Senegal
9
Mozambique
9
Congo, Democratic Republic of
9
Eswatini/ Swaziland
9
Haiti
8
Western Pacific Region
8
Chile
7
Venezuela
7
Germany
7
West and Central Africa
7
Russia
7
Thailand
6
Middle East and North Africa
6
Afghanistan
5
Moldova
5
Ecuador
5
Pakistan
5
Timor Leste/ East Timor
4
Cameroon
4
Laos
4
Burkina Faso
4
Jordan
4
Paraguay
4
Argentina
4
Lebanon
4
Sri Lanka
4
Yemen
4
Somalia
4
China
3
Vietnam
3
Egypt
3
Sudan
3
Palestine
3
Mali
3
Angola
3
Bhutan
3
North Macedonia
2
Tajikistan
2
El Salvador
2
Kyrgyzstan
2
Niger
2
Bulgaria
2
North America
2
United Kingdom
2
Belarus
2
Romania
2
Georgia
2
Central African Republic
2
Poland
2
Madagascar
2
North Korea
1
Australia
1
Gambia
1
Kazakhstan
1
Iran
1
Albania
1
Canada
1
Fiji
1
Singapore
1
Burundi
1
Peru
1
Mauritania
1
Guinea-Bissau
1
Hungary
1
Lithuania
1
Ireland
1
Turkmenistan
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Djibouti
1
Slovakia
1
Honduras
1
Chad
1
Iraq
1
Authors & Publishers
Publication Years
Category
Countries
911
Clinical Guidelines
391
Public Health
185
Women & Child Health
180
Key Resources
154
Capacity Building
51
Pharmacy & Technologies
34
Toolboxes
Mental Health
317
COVID-19
280
HIV
212
TB
204
Planetary Health
172
Pharmacy
97
Rapid Response
94
Caregiver
88
AMR
85
NTDs
77
NCDs
68
Ebola
65
Conflict
65
Global Health Education
58
Disability
50
Refugee
46
Specific Hazards
35
Natural Hazards
35
Zika
22
Polio
17
Cholera
16
Health Financing Toolbox
16
Social Ethics
4
Typhoon
1
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected.
Infection prevention and control (IP...
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
Health facilities in the Region of the Americas frequently suffer the effects of health emergencies and disasters, which jeopardize their ability to provide services to the population. The STAR-H methodology helps staff responsible for health emergency and disaster risk management to identify and as...
This toolkit was developed to provide detailed information and resources to support implementation of the WHO intrapartum and immediate postnatal care recommendations at the health-care facility level. The careful design of this toolkit is based on a rigorous evidence-based approach that includes im...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to health facilities or a qualified health care provider and do not receive the necessary care in a...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for...
This checklist is an operational tool to help national authorities develop or revise national respiratory pathogen (inclusive of influenza and coronaviruses) pandemic preparedness plans.
Prevention of stroke and transient ischemic attack includes both conventional approaches to vascular risk factor management (blood pressure lowering, cholesterol reduction with statins, smoking cessation and antiplatelet therapy)
and more specific interventions, such as carotid revascularization or...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
Through technical consultations with countries and partners, WHO has led the development of Preparedness and Resilience for Emerging Threats Module 1: Planning for respiratory pathogen pandemics. Version 1.0. The Module, currently available as an advanced draft, builds on previous pandemic lessons a...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
Hypertension is the number one health related risk factor in India, with the largest contribution to burden of disease and mortality. It contributes to an estimated 1.6 million deaths, due to ischemic heart disease and stroke, out of a total of about 10 million deaths annually in India. Fifty seven ...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
Medical devices are used for the prevention, diagnosis and treatment of illness and diseases and for rehabilitation. WHO developed guidance on medical device donation in 2011, which has been now reviewed, with new evidence, new references on considerations for medical device solicitation and provisi...
Several challenges face asthma management in Egypt, including the high percentage of uncontrolled patients, inadequate compliance, and overuse of short-acting beta-agonists (SABAs) leading to increased asthma-related morbidity and mortality. In this regard, the recent Global Initiative for Asthma (G...
